Title | Type | SJR | H index | Total Docs. (2001) | Total Docs. (3years) | Total Refs. (2001) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2001) | %Female (2001) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
516 | Acta Physiologica et Pharmacologica Bulgarica | journal | 0.107 Q4 | 16 | 42 | 43 | 0 | 5 | 43 | 0.12 | 0.00 | 38.03 | |
515 | Acta Physiologica Pharmacologica et Therapeutica Latinoamericana | journal | 0.175 Q3 | 13 | 0 | 66 | 0 | 24 | 65 | 0.21 | 0.00 | 0.00 | |
514 | Acta Technologiae et Legis Medicamenti | journal | 0.118 Q4 | 5 | 0 | 25 | 0 | 2 | 25 | 0.10 | 0.00 | 0.00 | |
513 | Advances in Antiviral Drug Design | book series | 0.330 Q2 | 12 | 0 | 7 | 0 | 7 | 5 | 1.00 | 0.00 | 0.00 | |
512 | Advances in Pharmacology | journal | 1.594 Q1 | 86 | 0 | 55 | 0 | 197 | 41 | 2.70 | 0.00 | 0.00 | |
511 | Alcoholism: Clinical and Experimental Research | journal | 1.149 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
510 | American Druggist | journal | 0.100 Q4 | 3 | 0 | 109 | 0 | 1 | 85 | 0.00 | 0.00 | 0.00 | |
509 | Antibiotics and chemotherapy | journal | 0.125 Q4 | 8 | 0 | 19 | 0 | 8 | 19 | 0.44 | 0.00 | 0.00 | |
508 | Anti-Cancer Drug Design | journal | 0.795 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
507 | Antiinfective Drugs and Chemotherapy | journal | 0.125 Q4 | 6 | 0 | 29 | 0 | 6 | 24 | 0.50 | 0.00 | 0.00 | |
506 | Antimicrobics and Infectious Diseases Newsletter | journal | 0.105 Q4 | 5 | 0 | 38 | 0 | 2 | 36 | 0.00 | 0.00 | 0.00 | |
505 | Autonomic and Autacoid Pharmacology | journal | 0.376 Q2 | 24 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
504 | Biotherapy | journal | 0.335 Q2 | 22 | 0 | 49 | 0 | 59 | 48 | 0.00 | 0.00 | 0.00 | |
503 | Birth Defects Research Part B - Developmental and Reproductive Toxicology | journal | 0.307 Q3 | 58 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
502 | Chemical Speciation and Bioavailability | journal | 0.400 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
501 | Ciencia Pharmaceutica | journal | 0.103 Q4 | 2 | 0 | 6 | 0 | 0 | 6 | 0.00 | 0.00 | 0.00 | |
500 | Clin-Alert | journal | 0.101 Q4 | 0 | 0 | 24 | 0 | 0 | 24 | 0.00 | 0.00 | 0.00 | |
499 | Current Issues in Pharmacy and Medical Sciences | journal | 0.101 Q4 | 13 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
498 | Current Opinion in Anti-inflammatory and Immunomodulatory Investigational Drugs | journal | 0.220 Q3 | 5 | 0 | 35 | 0 | 15 | 30 | 0.43 | 0.00 | 0.00 | |
497 | Current Protocols in Pharmacology | journal | 39 | 59 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 22.35 | ||
496 | Current protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.] | journal | 31 | 90 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 26.89 | ||
495 | Cytokines, Cellular and Molecular Therapy | journal | 0.549 Q2 | 28 | 0 | 84 | 0 | 127 | 84 | 1.16 | 0.00 | 0.00 | |
494 | Developments in Biological Standardization | journal | 0.315 Q3 | 44 | 0 | 313 | 0 | 297 | 313 | 0.64 | 0.00 | 0.00 | |
493 | Drug Design and Discovery | journal | 0.350 Q3 | 20 | 1 | 66 | 0 | 55 | 62 | 0.83 | 0.00 | 0.00 | |
492 | Drug Topics | journal | 0.106 Q4 | 8 | 321 | 1796 | 0 | 44 | 1283 | 0.03 | 0.00 | 47.92 | |
491 | Drugs in R and D | journal | 0.170 Q3 | 54 | 0 | 240 | 0 | 76 | 240 | 0.32 | 0.00 | 0.00 | |
490 | Gyogyszereszet | journal | 0.103 Q4 | 2 | 0 | 47 | 0 | 1 | 47 | 0.04 | 0.00 | 0.00 | |
489 | Hindustan Antibiotics Bulletin | journal | 0.101 Q4 | 10 | 0 | 19 | 0 | 1 | 19 | 0.00 | 0.00 | 0.00 | |
488 | IDMA Bulletin | journal | 0.110 Q4 | 1 | 0 | 8 | 0 | 0 | 2 | 0.00 | 0.00 | 0.00 | |
487 | Immunopharmacology | journal | 0.666 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
486 | Indian Journal of Forensic Medicine and Toxicology (discontinued) | journal | 0.144 Q4 | 16 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
485 | International Journal of Geriatric Psychopharmacology | journal | 0.411 Q1 | 11 | 0 | 75 | 0 | 102 | 71 | 0.41 | 0.00 | 0.00 | |
484 | International Journal of Immunopharmacology | journal | 0.325 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
483 | International Pharmacy Journal | journal | 0.103 Q4 | 4 | 0 | 131 | 0 | 3 | 107 | 0.01 | 0.00 | 0.00 | |
482 | Japanese Journal of Pharmacology | journal | 0.520 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
481 | Japanese Journal of Psychopharmacology | journal | 0.137 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
480 | Japanese Journal of Toxicology and Environmental Health | journal | 0.128 Q4 | 12 | 0 | 109 | 0 | 30 | 108 | 0.41 | 0.00 | 0.00 | |
479 | Journal of Anaesthesiology Clinical Pharmacology | journal | 0.100 Q4 | 42 | 0 | 207 | 0 | 4 | 170 | 0.02 | 0.00 | 0.00 | |
478 | Journal of Applied Therapeutic Research | journal | 0.117 Q4 | 8 | 0 | 51 | 0 | 3 | 51 | 0.04 | 0.00 | 0.00 | |
477 | Journal of Pharmacoepidemiology | journal | 0.166 Q3 | 5 | 0 | 11 | 0 | 1 | 9 | 0.09 | 0.00 | 0.00 | |
476 | Journal of Serotonin Research | journal | 0.263 Q3 | 8 | 0 | 6 | 0 | 5 | 6 | 0.00 | 0.00 | 0.00 | |
475 | Journal of Venomous Animals and Toxins | journal | 0.165 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
474 | Klinische Pharmakologie Aktuell | journal | 0.101 Q4 | 3 | 0 | 52 | 0 | 2 | 35 | 0.07 | 0.00 | 0.00 | |
473 | Lyon Pharmaceutique | journal | 0.101 Q4 | 3 | 0 | 37 | 0 | 2 | 35 | 0.00 | 0.00 | 0.00 | |
472 | Medical Letter on Drugs and Therapeutics | journal | 0.550 Q2 | 22 | 62 | 167 | 0 | 171 | 167 | 1.23 | 0.00 | 0.00 | |
471 | Molecular Diversity | journal | 0.290 Q4 | 63 | 0 | 51 | 0 | 52 | 50 | 0.15 | 0.00 | 0.00 | |
470 | National Toxicology Program technical report series | journal | 0.121 | 22 | 7 | 1 | 0 | 0 | 1 | 0.00 | 0.00 | 0.00 | |
469 | Natural Toxins | journal | 0.285 Q3 | 49 | 0 | 86 | 0 | 114 | 84 | 1.09 | 0.00 | 0.00 | |
468 | Perspectives in Drug Discovery and Design | journal | 0.508 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
467 | Pharmaceutica Acta Helvetiae | journal | 0.480 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®